SCBIO - About the company
SCBIO is a series B company based in Yuseong (South Korea), founded in 2021. It operates as a Developer of small molecule immuno-oncology drugs. SCBIO has raised $22.3M in funding. The company has 3250 active competitors, including 1119 funded and 771 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, BeiGene and Sana Biotechnology.
Company Details
Developer of small molecule immuno-oncology drugs. The company's lead compounds include 'SCB001' and 'SCB002', which are small-molecular compounds that regulate the activity of immune cells in tumors. It develops a pipeline for NSCLC, Pancreatic cancer, and more.
- Website
- sc-bio.co.kr
- Email ID
- *****@sc-bio.co.kr
- Phone Number
- +82 **********
Key Metrics
Founded Year
2021
Location
Yuseong, South Korea
Stage
Series B
Total Funding
$22.3M in 3 rounds
Latest Funding Round
Investors
Ranked
1106th among 3250 active competitors
Sign up to download SCBIO's company profile
SCBIO's funding and investors
SCBIO has raised a total funding of $22.3M over 3 rounds. Its first funding round was on 2022. Its latest funding round was a Series B round on Sep 01, 2025 for $*****. 9 investors participated in its latest round. SCBIO has 13 institutional investors.
Here is the list of recent funding rounds of SCBIO:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Sep 01, 2025 | 2931155 | Series B | 5446192 | 2674203 | 1815253 | 5437039 |
2023 | 2178 | Series A | 6550 | 3345 | 6791 | 4069 |
2022 | 5233 | Seed | 6222 | 5754 | 5762 | 3480 |
Access funding benchmarks and valuations. Sign up today!View details of SCBIO's funding rounds and investors
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
SCBIO's Competitors and alternates
Top competitors of SCBIO include Jazz Pharmaceuticals, BeiGene and Sana Biotechnology. Here is the list of Top 10 competitors of SCBIO, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Jazz Pharmaceuticals 2003, Dublin (Ireland), Public | Developer of novel biopharmaceutical medicines for unmet medical needs | $265M | 82/100 | |
2nd |  BeiGene 2010, Cambridge (United States), Public | Developer of targeted and immune-oncology drugs against cancer | $172M | 71/100 | |
3rd |  Sana Biotechnology 2018, Seattle (United States), Public | Developer of engineered cell therapies for treating various human diseases | $821M | 75/100 | |
4th | Senti Bio 2016, San Francisco (United States), Public | Developer of cell and gene therapies for patients living with incurable diseases | $158M | 72/100 | |
5th | Ideaya Biosciences 2015, San Francisco (United States), Public | Developer of oncology-focused precision medicine using molecular diagnostics | $157M | 72/100 | |
6th | Sutro Biopharma 2003, United States, Public | Developer of antibody-based therapeutics for cancer therapy | $175M | 72/100 | |
7th | Syndax 2005, Waltham (United States), Public | Developer of targeted therapies for the treatment of cancer | $198M | 72/100 | |
8th |  Moderna 2010, Cambridge (United States), Public | Developer of mRNA-based therapeutics for a wide range of diseases | $2.78B | 71/100 | |
9th | Karyopharm 2008, Newton (United States), Public | Biopharmaceutical company focused on developing and commercializing innovative cancer therapies | $98.4M | 71/100 | |
10th | C4 Therapeutics 2016, Cambridge (United States), Public | Developer of small molecule drugs for treating cancer | $223M | 71/100 | |
1106th |  SCBIO 2021, Yuseong (South Korea), Series B | Developer of small molecule immuno-oncology drugs | $22.3M | 40/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on SCBIO's competitors? Click here to see the top ones
SCBIO's Investments and acquisitions
SCBIO has made no investments or acquisitions yet.
Reports related to SCBIO
Here is the latest report on SCBIO's geography:
Are you a Founder ?
FAQs about SCBIO
Explore our recently published companies
- Elan Lifestyle - 2013 founded, Unfunded company
- Exborder - 2012 founded, Unfunded company
- Dwellerin - 2016 founded, Unfunded company
- Easetronics.com - 2004 founded, Unfunded company
- Edulabtech - Unfunded company
- Eduscanner.com - 2018 founded, Unfunded company
